HOUSTON, TX, March 4, 2026 (EZ Newswire) -- BrYet US, Inc. (“BrYet”) — a biotechnology innovator focused on developing curative therapies for advanced cancers — announced today that it has filed an ...
Molecular model of the tumor suppressor protein p53 (beige) bound to a molecule of DNA (red and blue). P53 maintains genomic stability by controlling cell division, repairing DNA damage, and ...
Milestone validates the clinical potential of BSI-082 as a synergistic combination partner for antibody-drug conjugates (ADCs) and reinforces Biosion's "In Global, For Global" collaboration strategy.
Solid-state battery developer QuantumScape announced it hit another key goal for 2025, beginning shipments of its B1 sample cells featuring separators produced using its proprietary Cobra process. The ...
Japanese utility firm Kyushu Electric Power has entered a strategic partnership with Taiwan-based ProLogium to jointly develop superfluid inorganic all-solid-state lithium battery 24V modules. Some ...
We preselected all newsletters you had before unsubscribing.
Factorial’s solid-state battery cells are being flight tested in Avidrone’s tandem-rotor long-range cargo drone. Credit: Avidrone Aerospace Factorial Energy has shipped its first solid-state ...
BOSTON--(BUSINESS WIRE)--Strand Therapeutics, a leader in next-generation mRNA-based therapeutics, today announced exciting preliminary Phase 1 clinical data for its lead investigational candidate, ...
VS-7375, an oral KRAS G12D inhibitor, received FDA clearance for clinical trials in advanced solid tumors, including pancreatic, colorectal, and non-small cell lung cancers. Verastem Oncology will ...
MELBOURNE, Fla.--(BUSINESS WIRE)--L3Harris Technologies (NYSE: LHX) has debuted an advanced large solid rocket motor to power the company’s air-launched, Medium Range Ballistic Missile (MRBM) target ...
ALTA3263 is designed for complete KRAS target coverage, which will be required to achieve breakthrough efficacy and safety for patients with KRAS-driven cancers SAN DIEGO--(BUSINESS WIRE)--Alterome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results